Meclocycline
![]() | |
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.309 |
| Chemical and physical data | |
| Formula | C22H21ClN2O8 |
| Molar mass | 476.87 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Meclocycline (INN) is a tetracycline antibiotic.[1] It is used topically (i.e. for skin infections)[2] as it is totally insoluble in water and may cause liver and kidney damage if given systemically.
Its production for medical use has been discontinued.[3] It was previously sold in the United States by Pfizer under the brand name Meclan.[4]
References
- ^ "Meclocycline sulfosalicylate". PubChem. U.S. National Library of Medicine. Retrieved 3 January 2019.
- ^ Gelmetti C (2008). "Local antibiotics in dermatology". Dermatologic Therapy. 21 (3): 187–95. doi:10.1111/j.1529-8019.2008.00190.x. PMID 18564249.
- ^ "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations". www.accessdata.fda.gov. Archived from the original on August 4, 2020. Retrieved 3 January 2019.
- ^ "MECLAN Drugs@FDA: FDA-Approved Drugs". www.accessdata.fda.gov. United States Food and Drug Administration. 11 August 2022. Archived from the original on September 16, 2024. Retrieved 2022-08-11.

